DRMITSUI MEDICAL HAEMORRHOID- phenylephrine hci witch hazel gel

ACTIVE INGREDIENT

Phenylephrine HCI 0.25% ,

Witch hazel 50%.
PURPOSE

ANAL DISTENDING PAIN.

MUCOSAL CONGESTION.

PROLAPSE OF HAEMORRHOIDS

INTERNAL & MIXED HAEMORRHOIDS.
KEEP OUT OF REACH OF CHILDREN

Keep Out of reach of children
WARNINGS

WARNINGS

For external use only.
DOSAGE & ADMINISTRATION

Apply externally to the affectedarea up to 4 times daily, especiallyat night, in the morning or aftereach bowel movement
INDICATIONS & USAGE

Swith an appropriate cleansing wipe.Gently dry by patting or blotting witha tissue or a soft cloth before applyinggel. When first opening the tube,puncture foil seal with topend of cap..Apply externally to the affectedarea up to 4 times daily, especiallyat night, in the morning or aftereach bowel movement..Childrenunder 12 years of age: ask a doctor.
INACTIVE INGREDIENT

Carbomer, Glycerol, Hydroxybenzoate ethyl ester, Triethanolamine, Purified water.
PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

DRMITSUI MEDICAL HAEMORRHOID
phenylephrine hci witch hazel gel

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
WITCH HAZEL (UNII: 101I4J0U34) (WITCH HAZEL - UNII:101I4J0U34)	WITCH HAZEL	50 g in 100 g
PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV)	PHENYLEPHRINE HYDROCHLORIDE	0.25 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
GLYCEROL, IODINATED (UNII: 8C0LU36AR9)
ETHYLPARABEN (UNII: 14255EXE39)
WATER (UNII: 059QF0KO0R)
CARBOMER (UNII: 0A5MM307FC)
TRIETHANOLAMINE (UNII: 9O3K93S3TK)

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC: 87267-011-01	5 in 1 BOX	05/10/2026
1		5 g in 1 TUBE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC Monograph Drug	M015	05/10/2026

Labeler - YIYANGYUAN LIFE SCIENCES (HONG KONG) CO., LIMITED (765303678)